Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background and Aims. Extremely preterm human infants have increased susceptibility to small bowel infection. We hypothesized that early colonization of the immature small intestine with Lactobacillus GG (LGG), and use of a recombinant lactoferrin (rhLF) to promote growth of LGG, would enhance gut defenses against enteroinvasive Eschericheria coli.Methods. Newborn rat pups were treated with nothing, intra-gastric LGG, or rhLF + LGG on days 3 and 4 of life. Gut colonization by LGG was quantified in lavaged jejunal and ileal fluid and gut wall homogenates on day 5 of life. Separate studies used similarly treated litters of newborn rats that were infected late on day 4 of life with E. coli[1012 CFU/kg]. Sixteen hours later, the numbers of E. coli were measured in small bowel fluid and gut wall homogenates.Results. Control pups initially had lactic acid bacteria colonize the bowel, but these bacteria were not LGG. Pups treated with LGG or rhLF + LGG had significantly higher numbers of LGG in the ileum versus jejunum. Contrary to our hypothesis, rhLF did not augment LGG colonization. After E. coli-related gut infection, planktonic [lavage fluid] and epithelia-adherent growth [gut wall homogenates] of E. coli in the small bowel were most effectively reduced by pre-treatment with rhLF and LGG (P<.05).Conclusion. Prophylactic therapy with recombinant human lactoferrin and the probiotic, Lactobacillus GG, act to enhance defenses against invasive E. coli in the nascent small intestine. We suggest that rhLF and LGG are therapeutic agents that may reduce necrotizing enterocolitis and gut-related sepsis in preterm human infants.
- Alander M, Satokari R, Korpela R, et al. 1999 Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65, 351-354.
- Bullen JJ, Rogers HJ, Leigh L. 1972 Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J 1(792), 69-72.
- Caplan MS, Miller-Catchpole R, Kaup S et al. 1999 Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117, 577-583.
- Claud EC, Walker WA. 2001 Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB 15, 1398-1403.
- Edde L, Hipolito RB, Hwang FFY, Headon DR, Shalwitz RA, Sherman MP. 2001 Lactoferrin protects neonatal rats from gut-related systemic infection. Amer J Physiol: Gastroenterol Liver Physiol 281, G1140-G1150.
- Gaynes RP, Edwards JR, Jarvis WR et al. 1996 Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 98, 357-361.
- Glantz SA. 1997. Primer of Biostatistics. New York, McGraw-Hill.
- Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC et al. 2000 Analysis of intestinal flora development in breast-fed and formulafed infants using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30, 61-67.
- Hooper LV, Gordon JI. 2001 Commensal host-bacterial relationships in the gut. Science 292, 1115-1118.
- Lönnerdal B, Iyer S. 1995 Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15, 93-110.
- Macfarlane GT, Cummings JH. 2002 Probiotics, infection and immunity. Curr Opin Infect Dis 15, 501-506.
- Masson PL, Heremans JF. 1971 Lactoferrin in milk from different species. Comp Biochem Physiol 39B, 119-129.
- Nichols BL, McKee, Putman M, Henry JF, Nichols VN. 1989 Human lactoferrin supplementation of infant formulas increases thymidine incorporation into the DNA of rat crypt cells. J Pediatr Gastroenterol Nutr 8, 102-109.
- Stoll BJ, Gordon T, Korones SB, et al. 1996 Late-onset sepsis in very low birth weight neonates: a report from the National Institutes of Child Health and Human Development Neonatal Research Network. J Pediatr 129, 63-71.
- Vanderhoof JA, Young RJ. 2002 Probiotics in pediatrics. Pediatrics 109, 956-958.
- Ward PP, Piddington CS, Cunningham G, Zhou X, Wyatt RD, Conneely OM. 1995 Development of a system for production of commercial quantities of human lactoferrin: a broad-spectrum natural antibiotic. Nature/Biotechnology 13, 498-503.
- Ward PP, Uribe-Luna S, Conneely OM. 2002 Lactoferrin and host defense. Biochem Cell Biol 80, 96-102.
- Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG
Volume 17, Issue 3 , pp 285-289
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Industry Sectors